MedTrace Logo

Leveraging the HIV Platform for Hypertension Control in Uganda (INTEGRATED HIV/HTN) STUDY

NCT04624061 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2600

Last updated 2022-11-04

No results posted yet for this study

Summary

The INTEGRATED HIV/HTN is a hybrid type-1 effectiveness/implementation cluster randomised trial evaluating the introduction of a multi-component integrated HIV/HTN care model intervention, randomised to 13 districts in the intervention arm compared to 13 districts in the control. Selected health facilities within the 13 intervention districts will receive the intervention while those in the 13 control districts will continue implementing the standard of care as per the Ministry of Health (MoH) guidelines. All the participating facilities will receive blood pressure (BP) machines, and Non- communicable diseases (NCDs) registers as a standard of care.

Conditions

Interventions

BEHAVIORAL

Integrated HIV/HTN care model

The intervention is a multi-component intervention of combined HIV and HTN care, based on the PRECEDE framework, to continuously identify barriers and facilitators leads to better health outcomes including dual control of HIV/HTN among adults in HIV care in the intervention compared to control facilities

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • Uganda Heart Institute

    collaborator OTHER

  • Ministry of Health, Uganda

    collaborator OTHER_GOV

  • London School of Hygiene and Tropical Medicine

    collaborator OTHER

  • Infectious Diseases Research Collaboration, Uganda

    lead OTHER

Principal Investigators

  • Jane Kabami, MPH · Infectious Diseases Research Collaboration, Uganda

  • Moses R Kamya, PhD · Infectious Diseases Research Collaboration, Uganda

  • Heiner Grosskurth, PhD · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-16
Primary Completion
2024-02-28
Completion
2024-02-28

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04624061 on ClinicalTrials.gov